397 related articles for article (PubMed ID: 36087287)
21. An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders.
Alghamdi M; Alasmari D; Assiri A; Mattar E; Aljaddawi AA; Alattas SG; Redwan EM
J Immunol Res; 2019; 2019():7592851. PubMed ID: 31886309
[TBL] [Abstract][Full Text] [Related]
22. Highlighting the versatility of the citrullination process.
Sarnik J; Makowska JS
Immunobiology; 2022 Jul; 227(4):152233. PubMed ID: 35667151
[TBL] [Abstract][Full Text] [Related]
23. Peptidylarginine deiminases and deiminated proteins at the epidermal barrier.
Cau L; Méchin MC; Simon M
Exp Dermatol; 2018 Aug; 27(8):852-858. PubMed ID: 29756256
[TBL] [Abstract][Full Text] [Related]
24. Citrullination regulates pluripotency and histone H1 binding to chromatin.
Christophorou MA; Castelo-Branco G; Halley-Stott RP; Oliveira CS; Loos R; Radzisheuskaya A; Mowen KA; Bertone P; Silva JC; Zernicka-Goetz M; Nielsen ML; Gurdon JB; Kouzarides T
Nature; 2014 Mar; 507(7490):104-8. PubMed ID: 24463520
[TBL] [Abstract][Full Text] [Related]
25. The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities.
Assohou-Luty C; Raijmakers R; Benckhuijsen WE; Stammen-Vogelzangs J; de Ru A; van Veelen PA; Franken KL; Drijfhout JW; Pruijn GJ
Biochim Biophys Acta; 2014 Apr; 1844(4):829-36. PubMed ID: 24594197
[TBL] [Abstract][Full Text] [Related]
26. Chemical biology of protein citrullination by the protein A arginine deiminases.
Mondal S; Thompson PR
Curr Opin Chem Biol; 2021 Aug; 63():19-27. PubMed ID: 33676233
[TBL] [Abstract][Full Text] [Related]
27. Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms.
Muller S; Radic M
Clin Rev Allergy Immunol; 2015 Oct; 49(2):232-9. PubMed ID: 25355199
[TBL] [Abstract][Full Text] [Related]
28. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation.
Zhang X; Bolt M; Guertin MJ; Chen W; Zhang S; Cherrington BD; Slade DJ; Dreyton CJ; Subramanian V; Bicker KL; Thompson PR; Mancini MA; Lis JT; Coonrod SA
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13331-6. PubMed ID: 22853951
[TBL] [Abstract][Full Text] [Related]
29. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
[TBL] [Abstract][Full Text] [Related]
30. Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases.
Méchin MC; Takahara H; Simon M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952341
[TBL] [Abstract][Full Text] [Related]
31. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
[TBL] [Abstract][Full Text] [Related]
32. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
[TBL] [Abstract][Full Text] [Related]
33. Role of protein deimination in cardiovascular diseases: potential new avenues for diagnostic and prognostic biomarkers.
Mao L; Mostafa R; Ibili E; Fert-Bober J
Expert Rev Proteomics; 2021 Dec; 18(12):1059-1071. PubMed ID: 34929115
[TBL] [Abstract][Full Text] [Related]
34. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
35. PADs and NETs in digestive system: From physiology to pathology.
Song YH; Wang ZJ; Kang L; He ZX; Zhao SB; Fang X; Li ZS; Wang SL; Bai Y
Front Immunol; 2023; 14():1077041. PubMed ID: 36761761
[TBL] [Abstract][Full Text] [Related]
36. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
37. Citrullination: A modification important in the pathogenesis of autoimmune diseases.
Zhu D; Song W; Jiang Z; Zhou H; Wang S
Clin Immunol; 2022 Dec; 245():109134. PubMed ID: 36184053
[TBL] [Abstract][Full Text] [Related]
38. Peptidylarginine Deiminase and Alzheimer's Disease.
Wang L; Chen H; Tang J; Guo Z; Wang Y
J Alzheimers Dis; 2022; 85(2):473-484. PubMed ID: 34842193
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
40. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Loos T; Mortier A; Gouwy M; Ronsse I; Put W; Lenaerts JP; Van Damme J; Proost P
Blood; 2008 Oct; 112(7):2648-56. PubMed ID: 18645041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
